Recro Pharma, Inc. (NASDAQ:REPH) headquartered in Malvern, will host a conference call for the investment community to discuss the 3Q20 financial results on 9th November 2020 at 8:00 AM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.recropharma.com
Earnings Expectation
Recro Pharma, Inc. is expected to report third quarter earnings results, before market open, on Monday 9th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.2 per share from revenue of $ 16.33 million. Looking ahead, the full year loss are expected at $ 0.97 per share on the revenues of $ 70.43 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 80.00 million ~ $ 85.00 million
Click Here For More Historical Outlooks Of Recro Pharma, Inc.
Recro Pharma, Inc. operates as a specialty pharmaceutical company. It operates through two divisions, an Acute Care, and Contract Development and Manufacturing (CDMO).
